Skip to main content

Table 3 Patient Demographics

From: Proteomic characterization of non-small cell lung cancer in a comprehensive translational thoracic oncology database

  Number of Cases (%)*
  Entire Database TMA only Heat map only
Gender
Male 688 (52) 63 (60) 46 (60)
Female 635 (48) 42 (40) 31 (40)
Race
Caucasian 587 (44) 63 (60) 51 (66)
African American 377 (28) 34 (32) 23 (30)
Other 38 (3) 2 (2) 3 (4)
Non-Specified 321 (24) 6 (6) n/a
Histology
Adenocarcinoma 603 (46) 58 (55) 51 (66)
Large Cell Carcinoma 75 (6) 18 (17) 15 (19)
Squamous Cell Carcinoma 338 (26) 15 (14) 11 (14)
NSCLC Non-Specified 307 (23) 14 (13) n/a
Stage
I 379 (29) 49 (47) 37 (48)
II 123 (9) 12 (11) 8 (10)
III 261 (20) 32 (30) 27 (35)
IV 173 (13) 6 (6) 5 (6)
Non-Specified 384 (29) 6 (6) n/a
Vital Status
Alive 537 (41) 32 (30) 24 (31)
Deceased 452 (34) 71 (68) 53 (69)
Unknown 334 (25) 2 (2) n/a
Mean Age at Diagnosis 64 years 61 years 61 years
Median Survival 17 months 16 months 17 months
Total NSCLC Cases 1323 105 77
  1. *Due to rounding, percentages may not sum to 100.
  2. To date, 1323 NSCLC patients have been captured in the database. A subset of these have TMA data (n = 105) and a further subset of patients were included in the heat map analysis.